| Lynn Kathleen Bickley, MD | |
|
6412 Church Hill Rd, Chestertown, MD 21620-2386 | |
| (410) 810-7090 | |
| (410) 810-7091 |
| Full Name | Lynn Kathleen Bickley |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 39 Years |
| Location | 6412 Church Hill Rd, Chestertown, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275521114 | NPI | - | NPPES |
| 475648 | Other | MD | MAMSI PLANS |
| K859TA | Other | MD | BLUE SHIELD |
| P000031306 | Other | MD | MC RAILROAD |
| W0170002 | Other | MD | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | D0047069 (Maryland) | Primary |
| 207NS0135X | Dermatology - Procedural Dermatology | D0047069 (Maryland) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Talbot Dermatology And Dermatologic Surgery Pa | 1254407760 | 2 |
News Archive
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre and University of Alberta could be a game changer for patients, improving both quality of life and longevity.
The Royal Pharmaceutical Society of Great Britain has welcomed the Centre for Reform's report, Online pharmacy: patient choice or patient peril, and warns that people are dicing with danger if they use rogue internet websites to bypass safety rules and obtain medicines without a doctor's prescription.
A new American Cancer Society study of twelve types of cancer among more than 3.5 million cancer patients finds uninsured patients were significantly more likely to present with advanced stage cancer compared to patients with private insurance.
› Verified 7 days ago
| Entity Name | Talbot Dermatology & Dermatologic Surgery Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184785370 PECOS PAC ID: 1254407760 Enrollment ID: O20081001000265 |
News Archive
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre and University of Alberta could be a game changer for patients, improving both quality of life and longevity.
The Royal Pharmaceutical Society of Great Britain has welcomed the Centre for Reform's report, Online pharmacy: patient choice or patient peril, and warns that people are dicing with danger if they use rogue internet websites to bypass safety rules and obtain medicines without a doctor's prescription.
A new American Cancer Society study of twelve types of cancer among more than 3.5 million cancer patients finds uninsured patients were significantly more likely to present with advanced stage cancer compared to patients with private insurance.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lynn Kathleen Bickley, MD Po Box 2350, Easton, MD 21601-8945 Ph: (410) 822-9890 | Lynn Kathleen Bickley, MD 6412 Church Hill Rd, Chestertown, MD 21620-2386 Ph: (410) 810-7090 |
News Archive
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre and University of Alberta could be a game changer for patients, improving both quality of life and longevity.
The Royal Pharmaceutical Society of Great Britain has welcomed the Centre for Reform's report, Online pharmacy: patient choice or patient peril, and warns that people are dicing with danger if they use rogue internet websites to bypass safety rules and obtain medicines without a doctor's prescription.
A new American Cancer Society study of twelve types of cancer among more than 3.5 million cancer patients finds uninsured patients were significantly more likely to present with advanced stage cancer compared to patients with private insurance.
› Verified 7 days ago
Dr. Tamy B Buckel, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 250 Haacke Dr, Chestertown, MD 21620 Phone: 410-778-0003 |